Steven Denbaars, Director at Aeluma, Inc. (ALMU), sold 25,000 shares at $15.85 ($418K) on 2026-02-26, disclosed to the SEC on 2026-02-27.
Scheduled sale ($418k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.58 | 12,500 | $220K | 52.6% |
| 2 | $15.85 | 12,500 | $198K | 47.4% |
| Total | $16.71 avg | 25,000 | $418K | 100% |
| Filing → |
| PrivatePalomino Laboratories Inc. | BUY | 2026-04-20 | $50K | — | Filing → |
| ALMU | BUY | 2025-05-23 | $100K | — | Filing → |
| AKTS | SELL | 2023-08-22 | $13K | — | Filing → |